feed,title,long_url,short_url
BioRxiv,mRNA-delivered neutralizing antibodies confer protection against SARS-CoV-2 variant in the lower and upper respiratory tract,https://www.biorxiv.org/content/10.1101/2025.04.28.650951v1?rss=1,https://da.gd/mhB5kd
BioRxiv,Highly potent antiviral drug candidates targeting SARS-CoV-2 nsp3 and nsp5,https://www.biorxiv.org/content/10.1101/2025.04.28.650947v1?rss=1,https://da.gd/Ds4D9
